Antares Pharma, Inc. (ATRS)

Revenue

$183.46M

TTM · Period ending: · USD

ATRS logo

ATRS Revenue

Latest reported$183.46M
ATRS TTM Revenue ($3.39M → $183.46M)
High-resolution chart · PNG

ATRS revenue history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Antares Pharma, Inc. Revenue — Trailing twelve months (TTM) (USD)
Period endingRevenue (USD)
183,456,000
183,982,000
179,385,000
171,197,000
158,603,000
149,599,000
143,305,000
137,608,000
133,657,000
123,864,000
104,846,000
88,408,000
74,137,000
63,554,000
58,771,985
55,956,382
55,210,541
54,515,000
54,672,136
53,098,502
51,910,733
52,222,046
49,829,845
47,436,834
49,628,835
45,658,100
42,256,284
37,741,113
29,647,507
26,501,665
22,844,471
21,781,714
21,292,473
20,618,500
21,374,767
21,552,860
20,239,258
22,575,578
22,501,436
20,734,556
19,753,487
16,458,492
14,313,022
13,516,045
13,024,159
12,818,698
12,118,776
11,037,888
9,648,745
8,311,062
7,497,055
6,844,465
6,572,736
5,660,711
5,869,384
5,711,476
6,127,636
7,856,996
7,896,707
7,422,657
6,475,477
4,268,399
2,986,337
2,673,691
2,307,021
2,224,746
2,206,368
2,375,565
2,574,520
2,745,956
2,958,833
3,385,617
3,602,539
3,786,844
3,823,703
4,016,605
4,236,916
3,995,761
4,238,890
3,602,786
3,580,326
3,498,524
2,577,519
2,435,662
2,096,363
1,993,241
2,487,663
2,532,763
2,365,909
3,481,862
3,050,868
3,250,868
3,450,868
2,750,868
3,617,023
3,517,023
3,617,023
3,717,023
3,791,804
4,091,804
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.